Labor and delivery:
Indications for: CERVIDIL
Cervical ripening in patients at or near term when there is an indication for labor induction.
Adult Dosage:
See full labeling.
Children Dosage:
Not established.
CERVIDIL Contraindications:
Evidence or suspicion of fetal distress where delivery is not imminent. Unexplained vaginal bleeding. Evidence or suspicion of marked cephalopelvic disproportion. Conditions for which labor induction, oxytocics are inappropriate or prolonged uterine contractions may be detrimental to fetal safety. Previous cesarean section or other uterine surgery expected to affect uterine integrity (eg, myomectomy). Six or more previous term pregnancies. Concomitant IV oxytocics.
CERVIDIL Warnings/Precautions:
For hospital use when appropriate obstetric care is present. Increased risk of postpartum disseminated intravascular coagulation (eg, ≥30yrs of age, complications during pregnancy, gestational age >40weeks); assess for evolving fibrinolysis in the immediate postpartum period. Monitor for amniotic fluid embolism syndrome. Glaucoma. Monitor uterine activity, fetal status, cervical dilatation/effacement. Remove insert if uterine tachysystole, uterine hypersystole/hypertonicity, fetal distress, or if labor commences, and prior to amniotomy or following rupture of membranes. Pregnancy.
CERVIDIL Interactions:
Potentiates oxytocics; delay administration of oxytocics at least 30mins after removal of insert.
Adverse Reactions:
Uterine tachysystole with/without fetal distress, fetal distress without uterine tachysystole.
How Supplied:
Insert—1
